Sandra E Juul is an expert in Pediatrics at University of Washington (United States). As of October 2026, ScienceLeadR ranks Sandra E Juul in the top 1% of experts worldwide for Asphyxia Neonatorum and Brain Injuries. Sandra E Juul has authored 325 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 3 of them ongoing. SLR score: 1,444 (community average: 125). How the SLR is computed.

LeadR Profile

Sandra E Juul University of Washington United States
1 444 ScienceLeadR Reputation 1444
Network Map

Pediatrics

Subspecialties: Neurology - Neonatology - Obstetrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

University of Washington

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 325

Citations

Citations: 12 364 1st author: 51 Last author: 93 Unique author: 12


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Adaptive Behavior Development and Autism Outcomes: A Comparison of Elevated- and Low-Likelihood Cohorts.
PMID 42830483 — motor skills, parturition, communication, autistic disorder, siblings, child
Autism20260
Validity Evidence for the Better Research Interactions for Every Family (BRIEF) Assessment Tool.
PMID 42669018 — pilots, self-assessment, physicians, research
Cureus20260
Barriers and facilitators to neurodevelopmental follow-up among at-risk newborns across Washington State.
PMID 42575924 — infant, newborn, perinatology, neurodevelopment
J Perinatol20260
Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.
PMID 42507461 — pregnancy, safety, parturition, brain diseases, cognition disorders, hypothermia, erythropoietin, brain ischemia, therapeutics, pediatrics, paralysis, cerebral palsy, infant
JAMA Pediatr20260
Effect of Caffeine on Cell Death, Oxidative Stress, and Microglial Morphology in a Ferret Organotypic Brain Slice Model of Hypoxia-Ischemia.
PMID 42496326 — microglia, cells, genes, stress, physiological, brain, oxidative stress, hypoxia, caffeine, cell death, ischemia
NeuroSci20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 4
N/A 2
Phase 1 1
Phase 1/Phase 2 1
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 6
Recruiting 3
Unknown 1

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195 — injections, epoetin alfa, safety, infant, newborn, brain, income, intensive care, neonatal, brain diseases, hypothermia, erythropoietin, asphyxia, therapeutics, asphyxia neonatorum
Phase 3Recruiting2022
Prevention of Developmental Delay and Xylitol (PDDaX) Study
NCT05361122 — oral health, chewing gum, pregnancy, mothers, parturition, follow-up studies, neurodevelopmental disorders, gingiva, prenatal education, xylitol, aged, dentists, premature birth, education, mastication, child, neurodevelopment
N/ARecruiting2023
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
NCT05340465 — injections, blood, parturition, anemia, iron-dextran complex, infant, premature, anemia, iron-deficiency, darbepoetin alfa, heme, ferritins, premature birth, accidental falls, infant, iron deficiencies, neurodevelopment
Phase 2Recruiting2022

LeadR Networks

Main global connection map